Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G Prentice

Showing results (241-250 of 299) with videos related to

Pageof 30
Sort By:
Transplantation Proceedings|February 1, 1991
Interleukin-2 infusion after autologous bone marrow transplantation enhances hemopoietic regenerationH E Heslop, A S Duncombe, J E Reittie, et al.
Clinical and Experimental Immunology|March 1, 1986
T lymphocyte regeneration after transplantation of T cell depleted allogeneic bone marrowG Janossy, H G Prentice, J P Grob, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1991
Successful treatment of acute myeloid leukemia beyond first remission with autologous bone marrow transplantation using busulfan/cyclophosphamide and unpurged marrow: the British autograft group experienceR Chopra, A H Goldstone, A K McMillan, et al.
Blood|April 1, 1989
Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapyJ E Reittie, D Gottlieb, H E Heslop, et al.
Cellular Immunology|December 1, 1986
T-cell depletion of allogeneic bone marrow prevents acceleration of graft-versus-host disease induced by exogenous interleukin 2M Malkovský, M K Brenner, R Hunt, et al.
British Journal of Haematology|November 1, 1988
Relapse after allogeneic bone marrow transplantation for acute leukaemia: a survey by the E.B.M.T. of 117 casesF Frassoni, A J Barrett, A Grañena, et al.
Leukemia|July 1, 1994
E2A/HLF fusion cDNAs and the use of RT-PCR for the detection of minimal residual disease in t(17;19)(q22;p13) acute lymphoblastic leukemiaP E Devaraj, L Foroni, M Sekhar, et al.
Lancet (London, England)|March 26, 1994
Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study GroupH G Prentice, E Gluckman, R L Powles, et al.
Blood|December 9, 1998
Molecular typing shows a high level of HLA class I incompatibility in serologically well matched donor/patient pairs: implications for unrelated bone marrow donor selectionI Scott, J O'Shea, M Bunce, et al.
Bone Marrow Transplantation|April 1, 1987
Haemorrhagic cystitis in bone marrow transplantation patients: possible increased risk associated with prior busulphan therapyA E Thomas, J Patterson, H G Prentice, et al.
Pageof 30

Showing results (241-250 of 299) with videos related to

Sort By:
Pageof 30
Transplantation Proceedings|February 1, 1991
Interleukin-2 infusion after autologous bone marrow transplantation enhances hemopoietic regenerationH E Heslop, A S Duncombe, J E Reittie, et al.
Clinical and Experimental Immunology|March 1, 1986
T lymphocyte regeneration after transplantation of T cell depleted allogeneic bone marrowG Janossy, H G Prentice, J P Grob, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1991
Successful treatment of acute myeloid leukemia beyond first remission with autologous bone marrow transplantation using busulfan/cyclophosphamide and unpurged marrow: the British autograft group experienceR Chopra, A H Goldstone, A K McMillan, et al.
Blood|April 1, 1989
Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapyJ E Reittie, D Gottlieb, H E Heslop, et al.
Cellular Immunology|December 1, 1986
T-cell depletion of allogeneic bone marrow prevents acceleration of graft-versus-host disease induced by exogenous interleukin 2M Malkovský, M K Brenner, R Hunt, et al.
British Journal of Haematology|November 1, 1988
Relapse after allogeneic bone marrow transplantation for acute leukaemia: a survey by the E.B.M.T. of 117 casesF Frassoni, A J Barrett, A Grañena, et al.
Leukemia|July 1, 1994
E2A/HLF fusion cDNAs and the use of RT-PCR for the detection of minimal residual disease in t(17;19)(q22;p13) acute lymphoblastic leukemiaP E Devaraj, L Foroni, M Sekhar, et al.
Lancet (London, England)|March 26, 1994
Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study GroupH G Prentice, E Gluckman, R L Powles, et al.
Blood|December 9, 1998
Molecular typing shows a high level of HLA class I incompatibility in serologically well matched donor/patient pairs: implications for unrelated bone marrow donor selectionI Scott, J O'Shea, M Bunce, et al.
Bone Marrow Transplantation|April 1, 1987
Haemorrhagic cystitis in bone marrow transplantation patients: possible increased risk associated with prior busulphan therapyA E Thomas, J Patterson, H G Prentice, et al.
Pageof 30